Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 11, 2007. The document serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by four individuals on January 10, 2007, at a price of GBP 13.60 per share. These transactions occurred under the Company's ShareReward Plan (entered into on October 5, 2001). The individuals involved are:
- Mr. J S Heslop
- Mr. R Bondy
- Mr. D Learmouth
- Mr. A P Witty
Each individual acquired:
- 9 Ordinary Shares under the partnership element (personal contribution).
- 9 Ordinary Shares under the matching element (Company contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the specific share transactions described above in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Investor Verification Points
- Verify the share price of GBP 13.60 per Ordinary Share on January 10, 2007.
- Confirm the total number of shares acquired by each named director (18 shares per person: 9 personal + 9 matching).
- Review the terms of the ShareReward Plan entered into on October 5, 2001, to understand the matching contribution structure.